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INTRODUCTION
The rapid development of nanotechnology – the key technology of the 
21th century - demands a consideration of risks and assessment of 
health effects during exposures to nanomaterials.
Due to their high surface to volume ratio, nanoscaled materials exhibit 
exceptional physical and chemical properties when compared to larger 
particles of the same composition. Therefore toxicological informations
of the bulk material should be carefully applied to nano particles.
One of the most relevant uptake pathways is the inhalation of 
nanoscaled particles. Effects on the respiratory tract like inflammation, 
oxidative stress and pulmonary fibrosis, adverse effects on the 
cardiovascular and central nervous system are considered. 
In addition, nanotubes with their structure similar to asbestos-fibres 
may have a carcinogenic potential.
Taking into consideration the various possible working mechanism of 
nanomaterials, an extensive diagnostic program was designed and 
offered to a collective of employees in chemical nanotechnology.
STUDY GROUP AND DIAGNOSTIC PROGRAM
The study group included 10 persons (3 woman, 7 men, mean age 
42,7 years) involved in production, modification of surface and further 
processing of oxide nano particles with primary particle size < 10 to 
100 nm for more than 11 years (figures 1 - 4). Medical examinations 
were carried out according to specified criteria set by us in 2009.
RESULTS
Half of the non smoking group showed a relevant obstructive 
ventilation disorder (with/without lung emphysema) in pulmonary 
function tests (figures 5 & 6). Correlating conjunctivitis, rhinitis and 
dyspnea – even at the workplace – were described in history.
X-rays of chest showed a lung emphysema in 5 out of 10 persons, in
3 cases signs of pulmonary emphysema were confirmed by CT 
scanning (figures 7 & 8).
Only 2 out of 5 persons with lung emphysema/obstruction presented 
a sensitization to IgE-mediated inhalative and immediate type 
allergens as a result of serologic tests and cutaneous allergy 
diagnostic according to an atopic diathesis.
Additionally, half of the group showed a positive LTT reaction to 
Zirconium – without clinical correlation to a manifest (type IV-) allergy. 
As a nano particle ZrO2 occupies the central position in the here 
shown exposition spectrum. One subject additionally showed a type I-
sensitization to Zirconium. Here allergic rhinitis and chronic bronchitis 
are of clinical relevance.
CONCLUSION
These findings indicate that long-term exposure in nanotechnology 
may be related to potentially adverse health effects. Adequate health 
and safety measures as well as surveillance by an occupational 
physician should be encouraged.
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Figures 1, 2, 3 & 4: 
Handling of nanomaterials during
processing.
Figure 7:
Chest X-ray:  Emphysema of the lung.
Figure 8:
CT scan of the lung:
Centrilobular emphysema accompanied by few small nodules.
Figures 5 & 6:
Body plethysmography (on the left resistance plots, on the right flow-volume curves): 
Obstructive ventilation disorder and emphysema.
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